Page last updated: 2024-08-24

mci-196 and Secondary Hyperparathyroidism

mci-196 has been researched along with Secondary Hyperparathyroidism in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Date, T; Funakoshi, S; Hashiguchi, J; Itoh, K; Kono, T; Kubo, H; Masaki, K; Nakano, H; Shigematsu, T; Tanaka, M; Uchino, J1
Dimkovic, N; Locatelli, F; Spasovski, G1
Andrés, E; Ballarín, J; Barceló, P; Bover, J; Ortiz-Herbener, F1

Reviews

2 review(s) available for mci-196 and Secondary Hyperparathyroidism

ArticleYear
Efficacy of colestilan in the treatment of hyperphosphataemia in renal disease patients.
    Expert opinion on pharmacotherapy, 2014, Volume: 15, Issue:10

    Topics: Bile Acids and Salts; Calcium; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Phosphates; Renal Dialysis; Renal Insufficiency, Chronic

2014
[New therapy strategies in secondary hyperparathyroidism on dialysis (I): new concepts, new treatments].
    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2005, Volume: 25 Suppl 2

    Topics: Algorithms; Bile Acids and Salts; Calcium; Cardiovascular Diseases; Disease Progression; Drug Therapy, Combination; Epoxy Compounds; Female; Ferric Compounds; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Lanthanum; Male; Multivariate Analysis; Niacinamide; Phosphate-Binding Proteins; Phosphates; Phosphorus; Polyamines; Polyethylenes; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Renal Dialysis; Risk Factors; Sevelamer; Time Factors

2005

Trials

1 trial(s) available for mci-196 and Secondary Hyperparathyroidism

ArticleYear
Comparison of sevelamer hydrochloride with colestimide, administered alone or in combination with calcium carbonate, in patients on hemodialysis.
    Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2008, Volume: 12, Issue:2

    Topics: Adult; Aged; Calcium; Calcium Carbonate; Chelating Agents; Drug Therapy, Combination; Epichlorohydrin; Female; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Imidazoles; Japan; Kidney Failure, Chronic; Male; Middle Aged; Phosphorus; Polyamines; Prospective Studies; Renal Dialysis; Resins, Synthetic; Sevelamer

2008